Skip to main content
Premium Trial:

Request an Annual Quote

Luminex, EMD Millipore Extend Distribution Agreement

NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Tuesday it has extended its global supply and distribution agreement with EMD Millipore.

The deal with EMD Millipore, the Life Science division of Merck KGaA, is anticipated to further the development of protein assays by EMD Millipore for Luminex's xMAP platform, the Austin, Texas-based firm said. EMD Millipore also will continue to offer all of Luminex's xMAP systems, including the Magpix, Luminex 100/200, and Flexmap 3D.

Financial and other terms of the deal were not disclosed.

"This renewal of our partnership with Luminex ensures that EMD Millipore can provide customers with a complete solution for multiplexed protein detection — encompassing assay kits, instruments, software, and services — that will support them over the years," John Sweeney, head of the life sciences business at EMD Millipore, said in a statement.

EMD Millipore recently announced the availability of its Milliplex map human stem cell pluripotency kits and Milliplex map kits for cellular metabolism. The kits run on the Luminex platform.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.